Zacks Investment Research on MSN
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus
CapsoVision, Inc. CV recently announced that it has submitted a 510(k) application to the FDA for approval to add an AI-based ...
Zacks Investment Research on MSN
KRMD submits 510(k) to use FreedomEDGE system with oncology biologic
KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to ...
PARAMUS, N.J., Nov. 25, 2025 /PRNewswire/ -- Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners portfolio company, today announced its 63rd FDA 510(k) clearance ...
Hansen Medical has announced it has received FDA 510(k) clearance for its Magellan Robotic System for peripheral vascular interventions, according to a news release. The system is designed to ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to two devices, HyHub and HyHub Duo, that act as docking stations for dual vial ...
LOS ANGELES--(BUSINESS WIRE)--Ruthless Spine today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NavJam™ Jamshidi device, and as of today, U.S. Patent ...
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum ...
The Company’s Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures in the U.S. Annually CEO, President & Chairman to Present Live Webcast at the H.C.
(RTTNews) - Monogram Biosciences Inc.(MGRM), Monday announced that the U.S. Food and Drug Administration or FDA has granted 510(k) clearance for its Monogram mBôs TKA System, a robotic-assisted ...
Please provide your email address to receive an email when new articles are posted on . Amyloid plaques are one telltale sign of Alzheimer’s disease pathology in blood plasma. A blood-based diagnostic ...
LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA, eligible for PEA-PME ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results